Filing Flows › Invo Fertility (IVF) › Q4 2024
Invo Fertility (IVF) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Apr 30, 2025
Invo Fertility (IVF) reported revenue of $1.7M for the fourth quarter 2024 (Q4 2024), +22% from a year earlier and +18% from the quarter before. Operating margin was -235.8%, net earnings $4.6M (272.9% of revenue).
Invo Fertility, Q4 2024: revenue $1.7M (+22% year over year), operating margin -235.8%, net earnings $4.6M, operating cash flow −$617K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | +18% | +22% |
| Operating profit | −$4.0M | — | — |
| Net earnings | $4.6M | — | — |
| Operating cash flow | −$617K | — | — |
What changed
Revenue was $1.7M in Q4 2024, up 22% year over year and up 18% from the previous quarter.
Operating costs exceeded revenue by $4.0M, an operating margin of -235.8%. Total costs grew 96% against revenue growth of 22%. The fastest-growing cost line was Research & development (+8107%). Net earnings were −$3.8M. The effective tax rate was -1.2%. Non-operating items added $8.5M, 187% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$617K. Non-cash charges added back $232K of depreciation and amortization. Working capital and other items used $5.5M. Capital expenditures of $79K exceeded it, leaving free cash flow of −$696K.
Questions
What was Invo Fertility's revenue in the fourth quarter 2024?
Invo Fertility (IVF) reported revenue of $1.7M for the fourth quarter 2024 (Q4 2024), +22% from a year earlier and +18% from the quarter before.
Was Invo Fertility profitable in the fourth quarter 2024?
Operating loss was $4.0M (-235.8% of revenue) and net earnings $4.6M.
Source: Invo Fertility 10-K on SEC EDGAR.